Home/Filings/4/0001225208-14-021204
4//SEC Filing

THRESHOLD PHARMACEUTICALS INC 4

Accession 0001225208-14-021204

CIK 0001183765operating

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 7:10 PM ET

Size

21.1 KB

Accession

0001225208-14-021204

Insider Transaction Report

Form 4
Period: 2014-10-01
Transactions
  • Exercise of In-Money

    Common Stock

    2014-10-01$2.05/sh+26,509$54,343126,887 total(indirect: By Trust)
  • Sale

    Common Stock

    2014-10-01$3.77/sh14,407$54,343112,480 total(indirect: By Trust)
  • Sale

    Common Stock

    2014-10-01$3.77/sh1,332$5,02489,275 total(indirect: By Trust)
  • Exercise of In-Money

    Common Stock Warrant

    2014-10-01417,0500 total(indirect: By Partnership)
    Exercise: $2.05From: 2009-10-05Exp: 2014-10-05Common Stock (417,050 underlying)
  • Exercise of In-Money

    Common Stock Warrant

    2014-10-012,4520 total(indirect: By Trust)
    Exercise: $2.05From: 2009-10-05Exp: 2014-10-05Common Stock (2,452 underlying)
  • Exercise of In-Money

    Common Stock Warrant

    2014-10-0126,5090 total(indirect: By Trust)
    Exercise: $2.05From: 2009-10-05Exp: 2014-10-05Common Stock (26,509 underlying)
  • Exercise of In-Money

    Common Stock

    2014-10-01$2.05/sh+2,452$5,02790,607 total(indirect: By Trust)
  • Exercise of In-Money

    Common Stock

    2014-10-01$2.05/sh+417,050$854,9524,942,055 total(indirect: By Partnership)
  • Sale

    Common Stock

    2014-10-01$3.77/sh226,657$854,9504,715,398 total(indirect: By Partnership)
Holdings
  • Common Stock

    (indirect: By Partnership)
    71,752
Footnotes (5)
  • [F1]Shares held by Sutter Hill Ventures, a California Limited Partnership. The reporting person is a Managing Director of the General Partner of Sutter Hill Ventures, a California Limited Partnership. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
  • [F2]On October 1, 2014, the reporting person exercised a warrant to purchase shares of the issuer's common stock for $2.05 per share. In accordance with the terms of the warrant, the exercise price was paid on a net basis. The shares disposed of in column 4 represent the number of shares of common stock withheld by the issuer to pay the exercise price.
  • [F3]Shares held by SHV Profit Sharing Plan, a retirement trust, for the benefit of the reporting person.
  • [F4]Shares held by a trust of which the reporting person is the trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
  • [F5]Shares held by a limited partnership of which the reporting person is the trustee of a trust which is the General Partner. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

Documents

1 file

Issuer

THRESHOLD PHARMACEUTICALS INC

CIK 0001183765

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001183765

Filing Metadata

Form type
4
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 7:10 PM ET
Size
21.1 KB